CVS Health Corporation Stock (CVS) - Quote Nyse- MarketScreener (2024)

CVS HEALTH CORPORATION

Add to a list

To use this feature you must be a member

Log inSign up

Equities

CVS

US1266501006

Market Closed - Nyse Other stock markets 04:00:02 2024-08-21 pm EDT			5-day change	1st Jan Change
58.32 ^USD	-0.98%		+4.50%	-26.14%

Aug. 19	Argus Adjusts Price Target on CVS Health to $75 From $80, Maintains Buy Rating	MT
Aug. 19	Venture capital firms making bets on maternal health	RE

Summary

Quotes

Charts

News

Company

Financials

Valuation

Consensus

Ratings

Calendar

Sector

ETFs

Valuation: CVS Health Corporation

(USD)

Capitalization	73.37B	P/E ratio 2024 *	11.2x	P/E ratio 2025 *	9.42x
Enterprise value	124B	EV / Sales 2024 *	0.34x	EV / Sales 2025 *	0.31x
Free-Float	70.63%	Yield 2024 *	4.5%	Yield 2025 *	4.72%

More valuation ratios * Estimated data

Chart: CVS Health Corporation

Duration

Period

Style

Dynamic Chart

Latest news: CVS Health Corporation

Argus Adjusts Price Target on CVS Health to $75 From $80, Maintains Buy Rating	Aug. 19	MT
Venture capital firms making bets on maternal health	Aug. 19	RE
Doctors struggle to get Wegovy for older Americans with heart disease	Aug. 15	RE
Hedge fund Sachem Head built CVS stake during second quarter	Aug. 14	RE
CVS Health Appoints Heidi Capozzi as Chief People Officer	Aug. 14	MT
CVS Health Corporation Appoints Heidi Capozzi as Executive Vice President, Chief People Officer, Effective September 9, 2024	Aug. 14	CI
Mizuho Adjusts Price Target on CVS Health to $66 From $72, Maintains Outperform Rating	Aug. 13	MT
Wells Fargo Adjusts Price Target on CVS Health to $61 From $60, Maintains Equalweight Rating	Aug. 12	MT
Top Midday Stories: e.l.f. Beauty Falls After Earnings; JetBlue's Potential Bond Sale; Perrigo Recalls Baby Formula; Cisco's Job Cuts	Aug. 09	MT
HSBC Adjusts Price Target on CVS Health to $61 From $62	Aug. 09	MT
Perrigo Recalls 16,500 Cans of Baby Formula Due to Elevated Vitamin D Levels	Aug. 09	MT
Perrigo recalls 16,500 cans of its infant formula	Aug. 09	RE
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	Aug. 08	MT

More news

Last Transcript: CVS Health Corporation

CVS Health Corporation, Q2 2024 Earnings Call, Aug 07, 2024

Aug. 07

More transcripts

Analysts' recommendations: CVS Health Corporation

Argus Adjusts Price Target on CVS Health to $75 From $80, Maintains Buy Rating	Aug. 19	MT
Hedge fund Sachem Head built CVS stake during second quarter	Aug. 14	RE
Mizuho Adjusts Price Target on CVS Health to $66 From $72, Maintains Outperform Rating	Aug. 13	MT
Wells Fargo Adjusts Price Target on CVS Health to $61 From $60, Maintains Equalweight Rating	Aug. 12	MT
HSBC Adjusts Price Target on CVS Health to $61 From $62	Aug. 09	MT

More recommendations

Press Releases: CVS Health Corporation

CVS Pharmacy® introduces colleague-designed journals	Aug. 21	PR
	Aug. 20	PR
CVS Health Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 10, 2024 to Discuss Your Rights - CVS	Aug. 19	PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadlines - CVS	Aug. 17	PR
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit	Aug. 16	PR

More press releases

News in other languages: CVS Health Corporation

Wall Street : la volatilité demeure élevée sur les indices	Aug. 08
EE.UU. - Valores a seguir en Wall Street (actualizado)	Aug. 07
Wall Street : une prolongation du rebond en vue	Aug. 07
Amgen : Airbnb, Hilton, Walt Disney...les valeurs à suivre aujourd'hui à Wall Street	Aug. 07
CVS Health : abaisse ses prévisions de BPA pour 2024	Aug. 07

More news

Quotes and Performance

1 day	-0.98%
1 week	+4.50%
Current month	-3.33%
1 month	-2.10%
3 months	+1.60%
6 months	-23.57%
Current year	-26.14%

More quotes

Course Extremes

1 week

55.75

59.24

1 month

55.60

63.92

Current year

52.77

83.25

1 year

52.77

83.25

3 years

52.77

111.25

5 years

52.04

111.25

10 years

51.72

113.65

More quotes

Managers and Directors: CVS Health Corporation

Director	Title	Age	Since
Karen Lynch CEO	Chief Executive Officer	61	18-11-27
David Falkowski CMP	Compliance Officer	-	11-02-28
Robin Peterson PRN	Corporate Officer/Principal	-	00-08-31

Manager	Title	Age	Since
C. Brown BRD	Director/Board Member	72	07-02-28
Jean-Pierre Millon BRD	Director/Board Member	73	07-02-28
Anne Finucane BRD	Director/Board Member	71	11-01-19

More insiders

ETFs: CVS Health Corporation

Name	Weight	AuM	1st Jan change	Investor Rating
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	3.92%	14 M€	+10.91%	-

More ETFs: CVS Health Corporation

Add to a list Add to a list 0 selected To use this feature you must be a member Log inSign up	Change	5d. change	1-year change	3-years change	Capi. ($)
CVS HEALTH CORPORATION	-0.98%	+4.50%	-13.06%	-30.76%	73.37B
HCA HEALTHCARE, INC.	+0.36%	+4.23%	+37.06%	+52.81%	97.21B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.45%	+11.85%	+17.49%	+68.09%	28.7B
	+0.53%	+4.37%	+10.34%	-29.97%	20.21B
LABCORP HOLDINGS INC.	+1.40%	+2.46%	+6.12%	-24.42%	19.21B
QUEST DIAGNOSTICS INCORPORATED	+1.37%	+1.70%	+15.11%	+0.90%	17.03B
UNIVERSAL HEALTH SERVICES, INC.	+0.11%	+4.62%	+77.55%	+51.01%	15.2B
TENET HEALTHCARE CORPORATION	+1.93%	+4.45%	+120.89%	+127.88%	15.16B
NATERA, INC.	+2.92%	+5.78%	+121.98%	+18.00%	15.08B
REDE D'OR SÃO LUIZ S.A.	+1.58%	+14.07%	+11.67%	-54.42%	13.74B
Average	+0.76%	+3.72%	+40.52%	+17.91%	31.49B
Weighted average by Cap.	+0.14%	+3.27%	+27.76%	+19.08%

See all sector performances

Financials

(USD)

	2024 *	2025 *
Net sales	369B	387B
Net income	6.68B	8.08B
Net Debt	50.71B	47.41B

More financial data * Estimated data

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursem*nt management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);- medical benefits management (25.8%);- other (0.1%).

Employees

259,500

Sector

Calendar

2024-10-29 - Q3 2024 Earnings Release (Projected)

Related indices

More about the company

Quotes

Date	Price	Change	Volume
24-08-21	58.32 $	-0.98%	4,730,369
24-08-20	58.90 $	+0.17%	4,178,664
24-08-19	58.80 $	+0.77%	7,469,140
24-08-16	58.35 $	+1.37%	7,442,666
24-08-15	57.56 $	+2.80%	10,041,033

Delayed Quote Nyse, August 21, 2024 at 04:00 pm EDT

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

58.32USD

Average target price

67.30USD

Spread / Average Target

+15.40%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Stock Market
Equities
CVS Stock

Our Free Content Help you Secure and Increase the Performance of Your Investments Secure my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '12230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });

CVS Health Corporation Stock (CVS) - Quote Nyse- MarketScreener (2024)

FAQs

What are analysts saying about CVS stock? ›

The average price target for CVS Health Corp is $66.15. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $86.00 ,the lowest forecast is $59.00. The average price target represents 18.15% Increase from the current price of $55.99.

Read The Full Story ›

Is CVS a good stock to buy right now? ›

Cvs Health Stock Forecast FAQ

Out of 15 analysts, 7 (46.67%) are recommending CVS as a Strong Buy, 1 (6.67%) are recommending CVS as a Buy, 7 (46.67%) are recommending CVS as a Hold, 0 (0%) are recommending CVS as a Sell, and 0 (0%) are recommending CVS as a Strong Sell.

Find Out More ›

What is the NYSE forecast for CVS? ›

Based on short-term price targets offered by 23 analysts, the average price target for CVS Health comes to $68.04. The forecasts range from a low of $59.00 to a high of $93.00. The average price target represents an increase of 15.71% from the last closing price of $58.80.

What is the future price of CVS stock? ›

Stock Price Forecast

The 19 analysts with 12-month price forecasts for CVS Health stock have an average target of 73.58, with a low estimate of 59 and a high estimate of 100. The average target predicts an increase of 24.93% from the current stock price of 58.90.

Why are CVS Group shares dropping? ›

Over the past year the shares are down 19%, impacted by a 30% drop in September 2023 after the CMA (Competition and Markets Authority) launched a vet sector review.

Read On ›

Did CVS stock split? ›

Stock split history for CVS Health (CVS)

The most recent stock split occurred on June 7th, 2005. One CVS share bought prior to May 3rd, 1983 would equal to 16 CVS shares today.

Keep Reading ›

Is CVS a buy, sell, or hold? ›

CVS Health stock has received a consensus rating of buy. The average rating score is and is based on 51 buy ratings, 14 hold ratings, and 0 sell ratings.

Find Out More ›

Who is CVS buying out? ›

March 30, 2023 - CVS has finalized its acquisition of the home healthcare company Signify Health, which aims to accelerate value-based care and improve health outcomes.

Keep Reading ›

How often does CVS pay dividends? ›

CVS Health Corporation's ( CVS ) ex-dividend date is July 22, 2024 , which means that buyers purchasing shares on or after that date will not be eligible to receive the next dividend payment. CVS Health Corporation ( CVS ) pays dividends on a quarterly basis.

Discover More ›

What is the growth forecast for CVS? ›

Future Growth

CVS Health is forecast to grow earnings and revenue by 10% and 4.8% per annum respectively. EPS is expected to grow by 10.8% per annum. Return on equity is forecast to be 11.7% in 3 years.

Get More Info ›

Is CVS Group a good investment? ›

Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. CVS Group's earnings over the next few years are expected to increase by 63%, indicating a highly optimistic future ahead.

Discover More ›